Antibiotic Is No More The Last Resort Of Treatment: Evidence Proves Antibiotic Resistant Bacteria Kills Woman

  • comments
  • print
  • email
Jan 17, 2017 06:29 AM EST

Antibiotic is always considered as the ultimate resort to tame the impact of bacteria, but some current incidents can destroy this concept. Yes, recently researchers have discovered a specific bacteria, which is resistant to all available antibiotics. The arena of medical science has no answer to this crucial problem.

According to Forbes, last year in September a female died from an infection caused by CRE or carbapenem-resistant Enterobacteriaceae. This bacteria was resistant to almost all the available antibiotics. Doctors tried all the possible procedures, but all efforts went in vain.

This incident is considered as the first example of the appearance of uber-resistant bacteria in the US. Uber-resistant bacteria indicates that bacteria, which is resistant to all antibiotics. It is assumed that more incidents can appear in the future. Even doctors are very much worried about the future consequences.

Recently the Morbidity and the Mortality Weekly Report (MMWR) of CDC has described the fact in detail. The women had a broken leg during her trip to India. She returned to the US with an infection in her right hip and admitted to a hospital in the Reno, Nevada. Doctors found that CRE bacteria were the key cause of the infection.

Doctors applied all possible antibiotics to treat the infection, but no positive result was found and the woman breathed her last. Centers for Disease Control and Prevention or the CDC director Tom Frieden called the CRE as the "phantom menace". It is clear that a fruitful change in the health policy is the need of the hour to stop the effect of CRE.

Though it is pathetic but true, that major modern medical inventions are losing the war against the bacteria. New powerful antibiotics can't kill the impact of CRE. The Pew Charitable Trusts organization reveals that a large number of antibiotics are made by small pharmaceutical companies.

The big pharmaceutical companies are not taking sufficient initiatives to create a major breakthrough to this problem. It is a common fact that infections are very common and every individual has to consume antibiotics at some point in life. But the question is if the antibiotics can't work properly after the first use, then what is the next solution?

Sources of Forbes reveal that different corners are raising important questions regarding the urgency of the proper action to tame the situation. Even the administration has not yet commented on this burning issue. Even no panel is made so far to address any development regarding the antibiotic resistant bacteria.

The urgent need is to identify the key opponent to defeat the enemy. Proper investigation and the perfect solution only can control the antibiotic resistant bacteria. It is necessary for the present generation to create a safe atmosphere for the future generation and rapid development in the arena of medical science can only do that. 

Join the Conversation
Real Time Analytics